153 related articles for article (PubMed ID: 2663906)
1. An assessment of the dual-analyte enzyme immunoassay for ovulation timing.
Lenton EA; King H; Johnson J; Amos S
Hum Reprod; 1989 May; 4(4):378-80. PubMed ID: 2663906
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
3. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
Stanczyk FZ; Miyakawa I; Goebelsmann U
Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
[TBL] [Abstract][Full Text] [Related]
4. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
5. Prediction of ovulation with the assessment of LH and the E1G/P2G ratio in urinary samples.
Baviera G; Carroccio G; Scurria L; Pizzi V; Scarselli G
Acta Eur Fertil; 1988; 19(3):139-42. PubMed ID: 3067480
[TBL] [Abstract][Full Text] [Related]
6. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
7. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
8. A prototype for ovulation detection: pros and cons.
Lasley BL; Shideler SE; Munro CJ
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
10. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
[TBL] [Abstract][Full Text] [Related]
11. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
12. The OVEIA assay, a simultaneous measurement of oestrone and pregnanediol glucuronides, for studying the treatment of infertility patients.
Anthony F; Aldrich C; Sharp NC; Smith EM; Masson GM; Dennis KJ
Hum Reprod; 1988 Oct; 3(7):870-2. PubMed ID: 3182977
[TBL] [Abstract][Full Text] [Related]
13. The OVEIA Dual Analyte assay--a new method for profiling the menstrual cycle.
Baker TS
Prog Clin Biol Res; 1988; 285():101-18. PubMed ID: 3231642
[TBL] [Abstract][Full Text] [Related]
14. Validation of the dual analyte assay of the oestrone:pregnanediol ratio in monitoring ovarian function.
Fabres C; Zegers-Hochschild F; Altieri E; Llados C
Hum Reprod; 1993 Feb; 8(2):208-10. PubMed ID: 8473420
[TBL] [Abstract][Full Text] [Related]
15. Enhanced follicle regulatory protein levels accompany reinitiation of ovulatory function after parturition.
Albertson BD; Rodgers KE; Tomai TP; Nolan-Watson K; Zinaman MJ; DiZerega GS
Am J Obstet Gynecol; 1992 Jul; 167(1):158-62. PubMed ID: 1442919
[TBL] [Abstract][Full Text] [Related]
16. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
[TBL] [Abstract][Full Text] [Related]
17. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
[TBL] [Abstract][Full Text] [Related]
18. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips.
Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S
Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the time of ovulation.
Garcia JE; Jones GS; Wright GL
Fertil Steril; 1981 Sep; 36(3):308-15. PubMed ID: 6456939
[TBL] [Abstract][Full Text] [Related]
20. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
